Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 166

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment

Open access
Ersche, Karen D, Sahakian, Barbara J · 2007 · Neuropsychology Review

Abstract

Chronic use of amphetamines and/or opiates has been associated with a wide range of cognitive deficits, involving domains of attention, inhibitory control, planning, decision-making, learning and memory. Although both amphetamine and opiate users show marked impairment in various aspects of cognitive function, the impairment profile is distinctly different according to the substance of abuse. In light of evidence showing that cognitive impairment in drug users has a negative impact on treatment engagement and efficacy, we review substance-specific deficits on executive and memory function, and discuss possibilities to address these during treatment intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11065-007-9033-y

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 211

  1. Adinoff, B., Devous, M. D., Cooper, D. B., Best, S. E., Chandler, P., Harris, T., et al. (2003). Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. American Journal of Psychiatry, 160, 1892–1894. · DOI
  2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.) Washington, DC: American Psychiatric Association.
  3. Amir, T., & Bahri, T. (1994). Effect of substance-abuse on visuographic function. Perceptual and Motor Skills, 78, 235–241. · DOI
  4. Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004). Inhibition and the right inferior frontal cortex. Trends in Cognitive Sciences, 8, 170–177. · DOI · Paper page
  5. Baddeley, A. (1986). Working memory. Oxford, U.K.: Clarendon.
  6. Baicy, K., & London, E. D. (2007). Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction, 102, 5–15. · DOI
  7. Ballon, J. S., & Feifel, D. (2006). A systematic review of modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry, 67, 554–566. · DOI · Paper page
  8. Bardo, M. T. (1998). Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens. Critical Reviews in Neurobiology, 12, 37–67. · DOI · Paper page
  9. Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, S. W., & Nathan, P. E. (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39, 376–389. · DOI · Paper page
  10. Bechara, A., Dolan, S., & Hindes, A. (2002). Decision-making and addiction (part II): Myopia for the future or hypersensitivity to reward? Neuropsychologia, 40, 1690–1705. · DOI · Paper page
  11. Bechara, A., & Martin, E. M. (2004). Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology, 18, 152–162. · DOI · Paper page
  12. Bell, M. D., Bryson, G. J., Greig, T. C., Fiszdon, J. M., & Wexler, B. E. (2005). Neurocognitive enhancement therapy with work therapy: Productivity outcomes at 6- and 12-month follow-ups. Journal of Rehabilitation Research and Development, 42, 829–838. · DOI
  13. Bench, C. J., Frith, C. D., Grasby, P. M., Friston, K. J., Paulesu, E., Frackowiak, R. S. J., et al. (1993). Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia, 31, 907–922. · DOI · Paper page
  14. Block, R. I., Bates, M. E., & Hall, J. A. (2003). Relation of premorbid cognitive abilities to substance users’ problems at treatment intake and improvements with substance abuse treatment and case management. American Journal of Drug and Alcohol Abuse, 29, 515–538. · DOI
  15. Bolla, K. I., Eldreth, D. A., London, E. D., Kiehl, K. A., Mouratidis, M., Contoreggi, C., et al. (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage, 19, 1085–1094. · DOI · Paper page
  16. Borgaro, S., Pogge, D. L., Deluca, V. A., Bilginer, L., Stokes, J., & Harvey, P. D. (2003). Convergence of different versions of the continuous performance test: Clinical and scientific implications. Journal of Clinical and Experimental Neuropsychology, 25, 283–292. · DOI
  17. Boys, A., Strang, J., & Homan, C. (1997). Have drug workers in England received appropriate training?: 1995 baseline data from a national survey. Drugs-Education Prevention and Policy, 4, 297–304. · doi:10.3109/09687639709028551
  18. Brust, J. C. M. (1998). Acute neurologic complications of drug and alcohol abuse. Neurologic Clinics, 16, 503–519. · DOI
  19. Burgess, P. W. (1997). Theory and methodology in executive function research. In P. Rabbitt (Ed.), Methodology of frontal and executive function. Hove, East Sussex: Psychology.
  20. Buttner, A., Mall, G., Penning, R., & Weis, S. (2000). The neuropathology of heroin abuse. Forensic Science International, 113, 435–442. · DOI · Paper page
  21. Buxton, N., & McConachie, N. S. (2000). Amphetamine abuse and intracranial haemorrhage. Journal of the Royal Society of Medicine, 93, 472–477. · doi:10.1177/014107680009300906
  22. Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder. Neuropsychopharmacology, 27, 699–711. · DOI · Paper page
  23. Chamberlain, S. R., Muller, U., Cleary, S., Robbins, T. W. & Sahakian, B. J. (2007). Atomoxetine increases salivary cortisol in healthy volunteers. Journal of Psychopharmacology (in press). · DOI
  24. Chamberlain, S. R., & Sahakian, B. J. (2007). The neuropsychiatry of impulsivity. Current Opinion in Psychiatry, 20, 255–261. · DOI · Paper page
  25. Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E. N., & Ernst, T. (2005). Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response. Biological Psychiatry, 57, 967–974. · DOI · Paper page
  26. Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research: Neuroimaging, 114, 65–79. · DOI · Paper page
  27. Chikazoe, J., Konishi, S., Asari, T., Jimura, K., & Miyashita, Y. (2007). Activation of right inferior frontal gyrus during response inhibition across response modalities. The Journal of Cognitive Neuroscience, 19, 69–80. · DOI · Paper page
  28. Clark, L., & Robbins, T. W. (2002). Decision-making deficits in drug addiction. Trends in Cognitive Sciences, 6, 361–363. · DOI
  29. Clark, L., Robbins, T. W., Ersche, K. D., & Sahakian, B. J. (2006). Reflection impulsivity in chronic and former substance users. Biological Psychiatry, 60, 512–522. · DOI · Paper page
  30. Cools, R. & Robbins, T. W. (2004). Chemistry of the adaptive mind. Philosophical Transactions of the Royal Society of London Series A-Mathematical Physical and Engineering Sciences, 362, 2871–2888. · DOI · Paper page
  31. Curran, H. V., Kleckham, J., Bearn, J., Strang, J., & Wanigaratne, S. (2001). Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose–response study. Psychopharmacology, 154, 153–160. · DOI
  32. Czuchry, M., & Dansereau, D. F. (2003a). Cognitive skills training: Impact on drug abuse counseling and readiness for treatment. American Journal of Drug and Alcohol Abuse, 29, 1–18. · DOI
  33. Czuchry, M., & Dansereau, D. F. (2003b). A model of the effects of node-link mapping on drug abuse counseling. Addictive Behaviors, 28, 537–549. · DOI
  34. Dagher, A., Owen, A. M., Boecker, H., & Brooks, D. J. (2001). The role of the striatum and hippocampus in planning: A PET activation study in Parkinson’s disease. Brain, 124, 1020–1032. · DOI · Paper page
  35. Daglish, M. R. C., & Nutt, D. J. (2003). Brain imaging studies in human addicts. European Neuropsychopharmacology, 13, 453–458. · DOI
  36. Danos, P., Kasper, S., Grunwald, F., Klemm, E., Krappel, C., Broich, K., et al. (1998a). Pathological regional blood flow in opiate-dependent patients during withdrawal: A HMPAO-SPECT study. Neuropsychobiology, 37, 194–199. · DOI
  37. Danos, P., Van Roos, D., Kasper, S., Bromel, T., Broich, K., Krappel, C. et al. (1998b). Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: A stereological CT study. Neuropsychobiology, 38, 80–83. · DOI
  38. Dansereau, D. F., & Dees, S. M. (2002). Mapping training: The transfer of a cognitive technology for improving counseling. Journal of Substance Abuse Treatment, 22, 219–230. · DOI
  39. Darke, S., Sims, J., McDonald, S., & Wickes, W. (2000). Cognitive impairment among methadone maintenance patients. Addiction, 95, 687–695. · DOI · Paper page
  40. Davis, P. E., Liddiard, H., & McMillan, T. M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67, 105–108. · DOI · Paper page
  41. de Lima, M. S., Soares, G. D., Reisser, A. A. P., & Farrell, M. (2002). Pharmacological treatment of cocaine dependence: A systematic review. Addiction, 97, 931–949. · DOI · Paper page
  42. De Vries, T. J., & Shippenberg, T. S. (2002). Neural systems underlying opiate addiction. Journal of Neuroscience, 22, 3321–3325. · DOI · Paper page
  43. Deakin, J. B., Aitken, M. R. F., Robbins, T. W., & Sahakian, B. J. (2004). Risk taking during decision-making in normal volunteers changes with age. Journal of the International Neuroscience Society, 10, 590–598.
  44. Derbyshire, S. W. G., Vogt, B. A., & Jones, A. K. P. (1998). Pain and Stroop interference tasks activate separate processing modules in anterior cingulate cortex. Experimental Brain Research, 118, 52–60. · DOI · Paper page
  45. Deroche-Gamonet, V., Darnaudery, M., Bruins-Slot, L., Piat, F., Le Moal, M., & Piazza, P. V. (2002). Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology, 161, 387–395. · DOI
  46. Di Chiara, G., & Imperato, A. (1986). Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: Studies with transcerebral dialysis in freely moving rats. Annals of the New York Academy of Sciences, 473, 367–381. · DOI · Paper page
  47. Dickman, S. J. (1990). Functional and dysfunctional impulsivity—personality and cognitive correlates. Journal of Personality and Social Psychology, 58, 95–102. · DOI · Paper page
  48. Dougherty, D. M., Bjork, J. M., Andrew Harper, R., Marsh, D. M., Gerard Moeller, F., Mathias, C. W., et al. (2003). Behavioral impulsivity paradigms: A comparison in hospitalized adolescents with disruptive behavior disorders. Journal of Child Psychology and Psychiatry, 44, 1145–1157. · DOI · Paper page
  49. Downes, J. J., Roberts, A. C., Sahakian, B. J., Evenden, J. L., Morris, R. G., & Robbins, T. W. (1989). Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: Evidence for a specific attentional dysfunction. Neuropsychologia, 27, 1329–1343. · DOI · Paper page
  50. Dursteler-MacFarland, K. M., Stormer, R., Seifritz, E., Hug, I., Muller-Spahn, F., Ladewig, D. et al. (2000). Opioid-associated effects on oxygen saturation in humans. Addiction, 95, 285–287. · DOI
  51. Elliott, R. (2003). Executive functions and their disorders. British Medical Bulletin, 65, 49–59. · DOI · Paper page
  52. Ernst, M., Grant, S. J., London, E. D., Contoreggi, C. S., Kimes, A. S., & Spurgeon, L. (2003). Decision making in adolescents with behavior disorders and adults with substance abuse. American Journal of Psychiatry, 160, 33–40. · DOI · Paper page
  53. Ernst, M., & Paulus, M. P. (2005). Neurobiology of decision making: A selective review from a neurocognitive and clinical perspective. Biological Psychiatry, 58, 596–604. · DOI · Paper page
  54. Ersche, K. D., Fletcher, P. C., Roiser, J. P., Fryer, T. D., London, M., Robbins, T. W., et al. (2006b). Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers. Psychopharmacology, 188, 364–373. · DOI
  55. Ersche, K. D., Roiser, J. P., Clark, L., London, M., Robbins, T. W., & Sahakian, B. J. (2005b). Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers. Neuropsychopharmacology, 30, 2115–2124. · DOI
  56. Eslinger, P. J., & Grattan, L. M. (1993). Frontal lobe and frontal–striatal substrates for different forms of human cognitive flexibility. Neuropsychologia, 31, 17–28. · DOI · Paper page
  57. FalsStewart, W. (1997). Ability of counselors to detect cognitive impairment among substance-abusing patients: An examination of diagnostic efficiency. Experimental and Clinical Psychopharmacology, 5, 39–50. · doi:10.1037/1064-1297.5.1.39
  58. FalsStewart, W., & Lucente, S. (1994a). Effect of neurocognitive status and personality functioning on length of stay in residential substance-abuse treatment—an integrative study. Psychology of Addictive Behaviors, 8, 179–190. · DOI
  59. FalsStewart, W., & Lucente, S. (1994b). The effect of cognitive rehabilitation on the neuropsychological status of patients in drug-abuse treatment who display neurocognitive impairment. Rehabilitation Psychology, 39, 75–94. · DOI
  60. FalsStewart, W., & Schafer, J. (1992). The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. Journal of Clinical Psychology, 48, 539–543. · DOI
  61. Ferraro, L., Antonelli, T., Tanganelli, S., O’Connor, W. T., de la Mora, M. P., Mendez-Franco, J., et al. (1999). The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: Prevention by local GABA(A) receptor blockade. Neuropsychopharmacology, 20, 346–356. · DOI
  62. Fishbain, D. A., Cutler, R. B., Rosomoff, H. L., & Rosomoff, R. S. (2003). Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. Journal of Pain and Symptom Management, 25, 559–577. · DOI
  63. Fishbein, D., Hyde, C., Eldreth, D., London, E. D., Matochik, J., Ernst, M., et al. (2005). Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers. Experimental and Clinical Psychopharmacology, 13, 25–40. · DOI
  64. Fishbein, D. H., Krupitsky, E., Flannery, B. A., Langevin, D. J., Bobashev, G., Verbitskaya, E., et al. (2007). Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug and Alcohol Dependence, 90, 25–38. · DOI
  65. Forman, S. D., Dougherty, G. G., Casey, B. J., Siegle, G. J., Braver, T. S., Barch, D. M., et al. (2004). Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biological Psychiatry, 55, 531–537. · DOI · Paper page
  66. Gabilondo, A. M., Meana, J. J., Barturen, F., Sastre, M., & Garciasevilla, J. A. (1994). Mu-opioid receptor and alpha(2)-adrenoceptor agonist binding-sites in the postmortem brain of heroin-addicts. Psychopharmacology, 115, 135–140. · DOI
  67. Galynker, I. I., Watras-Ganz, S., Miner, C., Rosenthal, R. N., Jarlais, D. C. D., Richman, B. L., et al. (2000). Cerebral metabolism in opiate-dependent subjects: Effects of methadone maintenance. Mount Sinai Journal of Medicine, 67, 381–387.
  68. Gastfriend, D. R., & McLellan, A. T. (1997). Treatment matching—Theoretic basis and practical implications. Medical Clinics of North America, 81, 945–966. · DOI
  69. Gehring, W. J., & Knight, R. T. (2000). Prefrontal–cingulate interactions in action monitoring. Nature Neuroscience, 3, 516–520. · DOI · Paper page
  70. Gerra, G., Calbiani, B., Zaimovic, A., Sartori, R., Ugolotti, G., Ippolito, L., et al. (1998). Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiatry Research-Neuroimaging, 83, 117–126. · DOI
  71. Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76, 181–190. · DOI
  72. Grant, D. A., & Berg, E. A. (1948). A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. Journal of Experimental Psychology, 38, 404–411. · DOI · Paper page
  73. Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, 1180–1187. · DOI · Paper page
  74. Gruber, S. A., Silveri, M. M., Renshaw, P. F., Tzilos, G. K., Pollack, M., Kaufman, M. J., et al. (2006). Methadone maintenance improves cognitive performance after two months of treatment. Experimental and Clinical Psychopharmacology, 14, 157–164. · DOI
  75. Guerra, D., Sole, A., Cami, J., & Tobena, A. (1987). Neuropsychological performance in opiate addicts after rapid detoxification. Drug and Alcohol Dependence, 20, 261–270. · DOI
  76. Haselhorst, R., Dursteler-MacFarland, K. M., Scheffler, K., Ladewig, D., Muller-Spahn, F., Stohler, R., et al. (2002). Frontocortical N-acetylaspartate reduction associated with long-term IV heroin use. Neurology, 58, 305–307. · doi:10.1212/wnl.58.2.305
  77. Hastie, R. (2001). Problems for judgment and decision making. Annual Review of Psychology, 52, 653–683. · DOI · Paper page
  78. Hester, R., Simoes-Franklin, C., & Garavan, H. (2007). Post-error behavior in active cocaine users: Poor awareness of errors in the presence of intact performance adjustments. Neuropsychopharmacology (in press). · DOI
  79. Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J., & Mitchell, S. H. (2006). Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology, 188, 162–170. · DOI · Paper page
  80. Hogarty, G. E., Flesher, S., Ulrich, R., Carter, M., Greenwald, D., Pogue-Geile, M., et al. (2004). Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry, 61, 866–876. · DOI · Paper page
  81. Hwang, J., Lyoo, I. K., Kim, S. J., Sung, Y. H., Bae, S., Cho, S. N., et al. (2006). Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. Drug and Alcohol Dependence, 82, 177–181. · DOI
  82. Jaffe, A. J., Rounsaville, B., Chang, G., Schottenfeld, R. S., Meyer, R. E., & OMalley, S. S. (1996). Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching. Journal of Consulting and Clinical Psychology, 64, 1044–1053. · DOI
  83. Jentsch, J. D., & Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology, 146, 373–390. · DOI · Paper page
  84. Jernigan, T. L., Gamst, A. C., Archibald, S. L., Fennema-Notestine, C., Mindt, M. R., Marcotte, T. L., et al. (2005). Effects of methamphetamine dependence and HIV infection on cerebral morphology. American Journal of Psychiatry, 162, 1461–1472. · DOI · Paper page
  85. Jollant, F., Bellivier, F., Leboyer, M., Astruc, B., Torres, S., Verdier, R., et al. (2005). Impaired decision making in suicide attempters. American Journal of Psychiatry, 162, 304–310. · DOI · Paper page
  86. Jollant, F., Guillaume, S., Jaussent, I., Castelnau, D., Malafosse, A., & Courtet, P. (2007). Impaired decision-making in suicide attempters may increase the risk of problems in affective relationships. Journal of Affective Disorders, 99, 59–62. · DOI
  87. Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry, 15, 215–220. · doi:10.1176/jnp.15.2.215 · Paper page
  88. Katz, E. C., King, S. D., Schwartz, R. P., Weintraub, E., Barksdale, W., Robinson, R., et al. (2005). Cognitive ability as a factor in engagement in drug abuse treatment. American Journal of Drug and Alcohol Abuse, 31, 359–369. · DOI
  89. Kaufman, J. N., Ross, T. J., Stein, E. A., & Garavan, H. (2003). Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience, 23, 7839–7843. · DOI · Paper page
  90. Kerwin, M. E., Walker-Smith, K., & Kirby, K. C. (2006). Comparative analysis of state requirements for the training of substance abuse and mental health counselors. Journal of Substance Abuse Treatment, 30, 173–181. · DOI
  91. Kim, S. J., Lyoo, I. K., Hwang, J., Chung, A., Sung, Y. H., Kim, J., et al. (2006). Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. International Journal of Neuropsychopharmacology, 9, 221–228. · DOI
  92. Kim, S. J., Lyoo, I. K., Hwang, J., Sung, Y. H., Lee, H. Y., Lee, D. S., et al. (2005a). Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology, 30, 1383–1391. · DOI
  93. Kim, S. J., Lyoo, I. K., Hwang, J., Sung, Y. H., Lee, H. Y., Lee, D. S. et al. (2005b). Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology, 30, 1383–1391. · DOI
  94. Kish, S. J., Kalasinsky, K. S., Derkach, P., Schmunk, G. A., Guttman, M., Ang, L., et al. (2001). Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology, 24, 561–567. · DOI
  95. Konishi, S., Nakajima, K., Uchida, I., Kameyama, M., Nakahara, K., Sekihara, K., et al. (1998b). Transient activation of inferior prefrontal cortex during cognitive set shifting. Nature Neuroscience, 1, 80–84. · DOI · Paper page
  96. Kosten, T. R., Scanley, B. E., Tucker, K. A., Oliveto, A., Prince, C., Sinha, R., et al. (2006). Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology, 31, 644–650. · DOI · Paper page
  97. Kumar, N. (2007). Nutritional neuropathies. Neurologic Clinics, 25, 209–255. · DOI
  98. Lee, T. M. C., Zhou, W. h., Luo, X. j., Yuen, K. S. L., Ruan, X. z., & Weng, X. c. (2005). Neural activity associated with cognitive regulation in heroin users: A fMRI study. Neuroscience Letters, 382, 211–216. · DOI
  99. Leland, D. S., & Paulus, M. P. (2005). Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults. Drug and Alcohol Dependence, 78, 83–90. · DOI
  100. Leung, H. C., Skudlarski, P., Gatenby, J. C., Peterson, B. S., & Gore, J. C. (2000). An event-related functional MRI study of the Stroop color word interference task. Cerebral Cortex, 10, 552–560. · DOI · Paper page
  101. Levine, A. J., Hardy, D. J., Miller, E., Castellon, S. A., Longshore, D., & Hinkin, C. H. (2006). The effect of recent stimulant use on sustained attention in HIV-Infected adults. Journal of Clinical and Experimental Neuropsychology, 28, 29–42. · DOI
  102. London, E. D., Berman, S. M., Voytek, B., Simon, S. L., Mandelkern, M. A., Monterosso, J., et al. (2005). Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biological Psychiatry, 58, 770–778. · DOI · Paper page
  103. London, E. D., Ernst, M., Grant, S., Bonson, K., & Weinstein, A. (2000). Orbitofrontal cortex and human drug abuse: Functional imaging. Cerebral Cortex, 10, 334–342. · DOI · Paper page
  104. London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., et al. (2004). Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry, 61, 73–84. · DOI · Paper page
  105. Lyvers, M. & Yakimoff, M. (2003). Neuropsychological correlates of opioid dependence and withdrawal. Addictive Behaviors, 28, 605–611. · DOI
  106. Mackin, R. S., Horner, M. D., Harvey, R. T., & Stevens, L. A. (2005). The relationship between neuropsychological measures and employment problems in outpatients with substance abuse. Rehabilitation Psychology, 50, 158–163. · DOI
  107. Malcolm, R., Book, S. W., Moak, D., DeVane, L., & Czepowicz, V. (2002). Clinical applications of modafinil in stimulant abusers: Low abuse potential. American Journal on Addictions, 11, 247–249. · DOI
  108. Manes, F., Sahakian, B. J., Clark, L., Rogers, R. D., Antoun, N., Aitken, M., et al. (2002). Decision-making processes following damage to the prefrontal cortex. Brain, 125, 624–639. · DOI · Paper page
  109. Mathew, R. J., & Wilson, W. H. (1991). Substance-Abuse and Cerebral Blood-Flow. American Journal of Psychiatry, 148, 292–305. · DOI
  110. McKetin, R., & Mattick, R. P. (1998). Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls. Drug and Alcohol Dependence, 50, 181–184. · DOI
  111. McLellan, A. T., Grissom, G. R., Zanis, D., Randall, M., Brill, P., & O’Brien, C. P. (1997). Problem-service ‘matching’ in addiction treatment. A prospective study in 4 programs. Archives of General Psychiatry, 54, 730–735. · DOI · Paper page
  112. Mehta, M. A., Manes, F. F., Magnolfi, G., Sahakian, B. J., & Robbins, T. W. (2004). Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D-2 receptor antagonist sulpiride in human volunteers. Psychopharmacology, 176, 331–342. · DOI · Paper page
  113. Mellers, B. A., Schwartz, A., & Cooke, A. D. J. (1998). Judgment and decision making. Annual Review of Psychology, 49, 447–477. · DOI · Paper page
  114. Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., et al. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose–response study. Pediatrics, 108, e83. · DOI · Paper page
  115. Mintzer, M. Z., Copersino, M. L., & Stitzer, M. L. (2005). Opioid abuse and cognitive performance. Drug and Alcohol Dependence, 78, 225–230. · DOI
  116. Mintzer, M. Z., & Stitzer, M. L. (2002). Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence, 67, 41–51. · DOI · Paper page
  117. Mitchell, D. G. V., Colledge, E., Leonard, A., & Blair, R. J. R. (2002). Risky decisions and response reversal: Is there evidence of orbitofrontal cortex dysfunction in psychopathic individuals? Neuropsychologia, 40, 2013–2022. · DOI · Paper page
  118. Monterosso, J., Ehrman, R., Napier, K. L., O’Brien, C. P., & Childress, A. R. (2001). Three decision-making tasks in cocaine-dependent patients: Do they measure the same construct? Addiction, 96, 1825–1837. · DOI · Paper page
  119. Moon, M., Do, K. S., Park, J., & Kim, D. (2007). Memory impairment in methamphetamine dependent patients. International Journal of Neuroscience, 117, 1–9. · DOI
  120. Morgenstern, J., & Bates, M. E. (1999). Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. Journal of Studies on Alcohol, 60, 846–855. · DOI
  121. Nagahama, Y., Okada, T., Katsumi, Y., Hayashi, T., Yamauchi, H., Oyanagi, C., et al. (2001). Dissociable mechanisms of attentional control within the human prefrontal cortex. Cerebral Cortex, 11, 85–92. · DOI · Paper page
  122. Neaigus, A., Gyarmathy, V. A., Zhao, M. F., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2007). Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. Journal of Infectious Diseases, 195, 1052–1061. · DOI
  123. Neiman, J., Haapaniemi, H. M., & Hillbom, M. (2000). Neurological complications of drug abuse: Pathophysiological mechanisms. European Journal of Neurology, 7, 595–606. · DOI · Paper page
  124. Nordahl, T. E., Salo, R., Natsuaki, Y., Galloway, G. P., Waters, C., Moore, C. D., et al. (2005). Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry, 62, 444–452. · DOI
  125. Nordahl, T. E., Salo, R., Possin, K., Gibson, D. R., Flynn, N., Leamon, M., et al. (2002). Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: A preliminary proton MRS study. Psychiatry Research: Neuroimaging, 116, 43–52. · DOI
  126. O’Brien, C. P., Dackis, C. A., & Kampman, K. (2006). Does modafinil produce euphoria? American Journal of Psychiatry, 163, 1109. · DOI
  127. Oh, J. S., Lyoo, I. K., Sung, Y. H., Hwang, J., Kim, J., Chung, A., et al. (2005). Shape changes of the corpus callosum in abstinent methamphetamine users. Neuroscience Letters, 384, 76–81. · DOI
  128. Ornstein, T. J., Iddon, J. L., Baldacchino, A. M., Sahakian, B. J., London, M., Everitt, B. J., et al. (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology, 23, 113–126. · DOI · Paper page
  129. Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990). Planning and spatial working memory following frontal-lobe lesions in man. Neuropsychologia, 28, 1021–1034. · DOI · Paper page
  130. Owen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995). Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia, 33, 1–24. · DOI · Paper page
  131. Papageorgiou, C. C., Liappas, I. A., Ventouras, E. M., Nikolaou, C. C., Kitsonas, E. N., Uzunoglu, N. K., et al. (2004). Long-term abstinence syndrome in heroin addicts: Indices of P300 alterations associated with a short memory task. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28, 1109–1115. · DOI
  132. Patton, J. H., Stanford, M. S., & Barratt, E. S. (1995). Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768–774. · DOI · Paper page
  133. Pau, C. W. H., Lee, T. M. C., & Chan, S. F. F. (2002). The impact of heroin on frontal executive functions. Archives of Clinical Neuropsychology, 17, 663–670. · doi:10.1093/arclin/17.7.663
  134. Paulus, M. P., Hozack, N., Frank, L., Brown, G. G., & Schuckit, M. A. (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biological Psychiatry, 53, 65–74. · DOI · Paper page
  135. Paulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005). Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry, 62, 761–768. · DOI · Paper page
  136. Pirastu, R., Fais, R., Messina, M., Bini, V., Spiga, S., Falconieri, D., et al. (2006). Impaired decision-making in opiate-dependent subjects: Effect of pharmacological therapies. Drug and Alcohol Dependence, 83, 163–168. · DOI
  137. Pitre, U., Dansereau, D. F., & Joe, G. W. (1996). Client education levels and the effectiveness of node-link maps. Journal of Addictive Diseases, 15, 27–44. · DOI
  138. Poulsen, E. J., Mannis, M. J., & Chang, S. D. (1996). Keratitis in methamphetamine abusers. Cornea, 15, 477-482. · doi:10.1097/00003226-199609000-00007
  139. Prosser, J., Cohen, L. J., Steinfeld, M., Eisenberg, D., London, E. D., & Galynker, I. I. (2006). Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug and Alcohol Dependence, 84, 240–247. · DOI
  140. Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V., Jokela, O., et al. (2006). Cognitive function during early abstinence from opioid dependence: A comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry, 6, 9. · DOI
  141. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1–14. · DOI · Paper page
  142. Robbins, T. W. (2005). Chemistry of the mind: Neurochemical modulation of prefrontal cortical function. Journal of Comparative Neurology, 493, 140–146. · DOI · Paper page
  143. Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., Lawrence, A. D., Mcinnes, L., et al. (1998). A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: Implications for theories of executive functioning and cognitive aging. Journal of the International Neuropsychological Society, 4, 474–490. · DOI · Paper page
  144. Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., Mcinnes, L., & Rabbitt, P. (1994). Cambridge neuropsychological test automated battery (Cantab)—a factor-analytic study of a large-sample of normal elderly volunteers. Dementia, 5, 266–281.
  145. Rogers, R. D., Andrews, T. C., Grasby, P. M., Brooks, D. J., & Robbins, T. W. (2000a). Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. Journal of Cognitive Neuroscience, 12, 142–162. · DOI · Paper page
  146. Rogers, R. D., Andrews, T. C., Grasby, P. M., Brooks, D. J., & Robbins, T. W. (2000b). Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. Journal of Cognitive Neuroscience, 12, 142–162. · DOI · Paper page
  147. Rogers, R. D., Owen, A. M., Middleton, H. C., Williams, E. J., Pickard, J. D., Sahakian, B. J., et al. (1999b). Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. Journal of Neuroscience, 19, 9029–9038. · DOI · Paper page
  148. Rogers, R. D. & Robbins, T. W. (2001). Investigating the neurocognitive deficits associated with chronic drug misuse. Current Opinion in Neurobiology, 11, 250–257. · DOI · Paper page
  149. Rogers, R. D., & Robbins, T. W. (2003). The neuropsychology of chronic drug abuse. In M. A. Ron & T. W. Robbins (Eds.), Disorders of brain and mind. Cambridge: Cambridge University Press.
  150. Rose, J. S., Branchey, M., BuydensBranchey, L., Stapleton, J. M., Chasten, K., Werrell, A., et al. (1996). Cerebral perfusion in early and late opiate withdrawal: A technetium-99m-HMPAO SPECT study. Psychiatry Research-Neuroimaging, 67, 39–47. · DOI
  151. Rotheram-Fuller, E., Shoptaw, S., Berman, S. M., & London, E. D. (2004). Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug and Alcohol Dependence, 73, 79–86. · DOI
  152. Rounsaville, B. J., Jones, C., Novelly, R. A., & Kleber, H. (1982). Neuropsychological functioning in opiate addicts. Journal of Nervous and Mental Disease, 170, 209–216. · DOI
  153. Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003). Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage, 20, 351–358. · DOI · Paper page
  154. Russo, K. E., Hall, W., Chi, O. Z., Sinha, A. K., & Weiss, H. R. (1991). Effect of amphetamine on cerebral blood flow and capillary perfusion. Brain Research, 542, 43-48. · DOI
  155. Rychtarik, R. G., Connors, G. J., Whitney, R. B., McGillicuddy, N. B., Fitterling, J. M., & Wirtz, P. W. (2000). Treatment settings for persons with alcoholism: Evidence for matching clients to inpatient versus outpatient care. Journal of Consulting and Clinical Psychology, 68, 277–289. · DOI
  156. Sacerdote, P. (2006). Opioids and the immune system. Palliative Medicine, 20, S9–S15. · DOI · Paper page
  157. Salo, R., Nordahl, T. E., Moore, C., Waters, C., Natsuaki, Y., Galloway, G. P., et al. (2005). A dissociation in attentional control: Evidence from methamphetamine dependence. Biological Psychiatry, 57, 310–313. · DOI
  158. Salo, R., Nordahl, T. E., Natsuaki, Y., Leamon, M. H., Galloway, G. P., Waters, C., et al. (2007). Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry, 61, 1272–1280. · DOI
  159. Salo, R., Nordahl, T. E., Possin, K., Leamon, M., Gibson, D. R., Galloway, G. P., et al. (2002). Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research, 111, 65–74. · DOI · Paper page
  160. Sarajuuri, J. M., Kaipio, M. L., Koskinen, S. K., Niemela, M. R., Servo, A. R., & Vilkki, J. S. (2005). Outcome of a comprehensive neurorehabilitation program for patients with traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 86, 2296–2302. · DOI
  161. Sarter, M., Givens, B., & Bruno, J. P. (2001). The cognitive neuroscience of sustained attention: Where top–down meets bottom–up. Brain Research Reviews, 35, 146–160. · DOI · Paper page
  162. Seiden, L. S., Sabol, K. E., & Ricaurte, G. A. (1993). Amphetamine: Effects on catecholamine systems and behavior. Annual Review of Pharmacology and Toxicology, 33, 639–676. · DOI · Paper page
  163. Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H. et al. (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry, 158, 1206–1214. · DOI · Paper page
  164. Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 298, 199–209. · DOI · Paper page
  165. Shearer, J. (2007). Psychosocial approaches to psychostimulant dependence: A systematic review. Journal of Substance Abuse Treatment, 32, 41–52. · DOI
  166. Simon, S. L., Domier, C., Carnell, J., Brethen, P., Rawson, R., & Ling, W. (2000). Cognitive impairment in individuals currently using methamphetamine. American Journal on Addictions, 9, 222–231. · DOI · Paper page
  167. Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2002). Cognitive performance of current methamphetamine and cocaine abusers. Journal of Addictive Diseases, 21, 61–74. · DOI · Paper page
  168. Spence, S. A., Green, R. D., Wilkinson, I. D., & Hunter, M. D. (2005). Modafinil modulates anterior cingulate function in chronic schizophrenia. British Journal of Psychiatry, 187, 55–61. · DOI
  169. Stern, R. A., Singer, E. A., Duke, L. M., Singer, N. G., Morey, C. E., Daughtrey, E. W., et al. (1994). The Boston qualitative scoring system for the Rey-Osterrieth complex figure-description and interrater reliability. Clinical Neuropsychologist, 8, 309–322. · DOI
  170. Stout, J. C., Rock, S. L., Campbell, M. C., Busemeyer, J. R., & Finn, P. R. (2005). Psychological processes underlying risky decisions in drug abusers. Addictive Behaviors, 19, 148–157. · DOI
  171. Stout, P. R., & Farrell, L. J. (2003). Opioids—effects on human performance and behavior. Forensic Science Review, 15, 30–59.
  172. Sung, Y. H., Cho, S. C., Hwang, J., Kim, S. J., Kim, H., Bae, S. et al. (2007). Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: A proton magnetic resonance spectroscopy study. Drug and Alcohol Dependence, 88, 28–35. · doi:10.1016/j.drugalcdep.2006.09.011
  173. Taneja, I., Haman, K., Shelton, R. C., & Robertson, D. (2007). A randomized, double-blind, crossover trial of modafinil on mood. Journal of Clinical Psychopharmacology, 27, 76–79. · DOI
  174. Tapert, S. F., Brown, S. A., Myers, M. G., & Granholm, E. (1999). The role of neurocognitive abilities in coping with adolescent relapse to alcohol and drug use. Journal of Studies on Alcohol, 60, 500–508. · DOI
  175. Tapert, S. F., Ozyurt, S. S., Myers, M. G., & Brown, S. A. (2004). Neurocognitive ability in adults coping with alcohol and drug relapse temptations. American Journal of Drug and Alcohol Abuse, 30, 445–460. · DOI
  176. Taylor, M. J., Letendre, S. L., Schweinsburg, B. C., Alhassoon, O. M., Brown, G. G., Gongvatana, A., et al. (2004). Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. Journal of the International Neuropsychological Society, 10, 110–113.
  177. Teichner, G., Horner, M. D., Roitzsch, J. C., Herron, J., & Thevos, A. (2002). Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addictive Behaviors, 27, 751–763. · DOI
  178. Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y. H., et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24, 6028–6036. · DOI · Paper page
  179. Toomey, R., Lyons, M. J., Eisen, S. A., Xian, H., Chantarujikapong, S., Seidman, L. J., et al. (2003). A twin study of the neuropsychological consequences of stimulant abuse. Archives of General Psychiatry, 60, 303–310. · DOI
  180. Tsai, G., & Coyle, J. T. (1995). N-Acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology, 46, 531–540. · DOI · Paper page
  181. Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004a). Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry, 55, 1031–1040. · DOI · Paper page
  182. Turner, D. C., Clark, L., Pomarol-Clotet, E., McKenna, P., Robbins, T. W., & Sahakian, B. J. (2004b). Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology, 29, 1363–1373. · DOI · Paper page
  183. U.K. Department of Health (1999). Drug misuse and dependence—guidelines on clinical management. Norwich, U.K.: The Stationery Office Ltd.
  184. United Nations Office on Drugs and Crime (2003a). Global illicit drug trends 2003. New York, NY: United Nations Office on Drugs and Crime (UNODC). · DOI
  185. United Nations Office on Drugs and Crime (2003b). World Drug Report 2004. (vols. 1: Analysis). Vienna, AU: United Nations Office on Drugs and Crime (UNODC).
  186. Urbina, A. & Jones, K. (2004). Crystal methamphetamine, its analogues, and HIV infection: Medical and psychiatric aspects of a new epidemic. Clinical Infectious Diseases, 38, 890–894. · doi:10.1086/381975
  187. van Honk, J., Hermans, E. J., Putman, P., Montague, B., & Schutter, D. J. L. G. (2002). Defective somatic markers in sub-clinical psychopathy. Neuroreport, 13, 1025–1027. · DOI · Paper page
  188. Varner, K. J., Ogden, B. A., Delcarpio, J., & Meleg-Smith, S. (2002). Cardiovascular Responses Elicited by the "Binge" Administration of Methamphetamine. Journal of Pharmacology and Experimental Therapeutics, 301, 152-159. · DOI
  189. Vassileva, J., Petkova, P., Georgiev, S., Martin, E. M., Tersiyski, R., Raycheva, M., et al. (2007). Impaired decision-making in psychopathic heroin addicts. Drug and Alcohol Dependence, 86, 287–289. · DOI
  190. Verdejo-Garcia, A., Lopez-Torrecillas, F., Gimenez, C. O., & Perez-Garcia, M. (2004). Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review, 14, 1–41. · DOI · Paper page
  191. Verdejo-Garcia, A. J., Perales, J. C., & Perez-Garcia, M. (2007). Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addictive Behaviors, 32, 950–966. · DOI · Paper page
  192. Verdejo-Garcia, A., & Perez-Garcia, M. (2007). Ecological assessment of executive functions in substance dependent individuals. Drug and Alcohol Dependence, Epub ahead of print (21 March 2007). · DOI
  193. Verdejo-Garcia, A., Toribio, I., Orozco, C., Puente, K. L., & Perez-Garcia, M. (2005). Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug and Alcohol Dependence, 78, 238–288.
  194. Virmani, A., Binienda, Z., Ali, S., & Gaetani, F. (2006). Links between nutrition, drug abuse, and the metabolic syndrome. · DOI
  195. Vocci, F. J., Acri, J., & Elkashef, A. (2005). Medication development for addictive disorders: The state of the science. American Journal of Psychiatry, 162, 1432–1440. · DOI · Paper page
  196. Vogt, B. A., Wiley, R. G., & Jensen, E. L. (1995). Localization of Mu-Opioid and Delta-Opioid Receptors to Anterior Cingulate Afferents and Projection Neurons and Input–Output Model of Mu Regulation. Experimental Neurology, 135, 83–92. · DOI
  197. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., et al. (2001b). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21, 9414–9418. · DOI · Paper page
  198. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M. J., et al. (2001c). Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. American Journal of Psychiatry, 158, 383–389. · DOI · Paper page
  199. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., et al. (2001d). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377–382. · DOI · Paper page
  200. Volkow, N. D., Fowler, J. S., & Wang, G. J. (2004a). The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology, 47, 3–13. · DOI · Paper page

200 of 211 shown

Cited by

See all 166

Metadata

Authors
Ersche, K. D., & Sahakian, B. J.
Venue
Neuropsychology Review
Published
2007-08-10
Volume
17
Issue
3
Pages
317-336
ISSN
  • 1040-7308 (ISSN-L)
  • 1573-6660
OpenAlex
W1971200832
Cited by
166
References
38
FWCI
5.23
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment. https://app.cochat.ai/papers/10.1007/s11065-007-9033-y
The paper
Ersche, K. D., & Sahakian, B. J. (2007). The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment. Neuropsychology Review. https://doi.org/10.1007/s11065-007-9033-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.